Skip to main content
Industry Update
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6
- Alex Simpson and
- Sreeram V Ramagopalan
pp473–475
Published Online:9 March 2022
Clinical Trial Protocol
Design and methods of a tailored approach for diabetes prevention in women with previous gestational diabetes
- Julie M Pike,
- Lisa G Yazel,
- Kathryn M Haberlin-Pittz,
- Luz A Machuca,
- Brett M McKinney, and
- Tamara S Hannon
pp477–487
Published Online:13 April 2022
Short Communication
Economic burden of lives lost due to COVID-19 in California State
- Michelle Zheng,
- Briana Lui,
- Axell-Giovanni A Komlan,
- Christina R Bonaparte,
- Robert S White, and
- Marguerite M Hoyler
pp489–498
Published Online:10 March 2022
Research Article
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms
- Julie Beyrer,
- Hamed Abedtash,
- Kenneth Hornbuckle, and
- James F Murray
pp499–511
Published Online:17 March 2022
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data
- Marco Ghiani,
- Ulf Maywald,
- Thomas Wilke, and
- Bart Heeg
pp513–521
Published Online:22 March 2022
Sex-based differences in the outcomes of patients with lung carcinoids
- Omar Abdel-Rahman,
- Sunita Ghosh, and
- Nicola Fazio
pp523–531
Published Online:7 April 2022
Review
Digital technologies in cancer care: a review from the clinician's perspective
- Logan G Briggs,
- Muhieddine Labban,
- Khalid Alkhatib,
- David-Dan Nguyen,
- Alexander P Cole, and
- Quoc-Dien Trinh
pp533–544
Published Online:13 April 2022
Corrigendum
Corrigendum
pp549–549
Published Online:3 March 2022
- Correction(s) for this article
Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation
- Volume 11Issue 3Journal of Comparative Effectiveness Research
- 24 January 2022